Evaluation of the Safety and Effectiveness of Aceclidine (LNZ101) and Aceclidine + Brimonidine (LNZ100) in the Treatment of Presbyopia

• Status: Recruiting
• Trial end date: 2022-09-01

Summary

To evaluate the safety and effectiveness of Aceclidine/Brimonidine (LNZ101) compared with Aceclidine (LNZ100) and vehicle in the treatment of Presbyopia.

• Phase: Phase 2

Details

• Lead Sponsor: Alisyn Facemire
• Collaborator: ORA, Inc.
• Treatments: Aceclidine; Brimonidine Tartrate; Ophthalmic Solutions; Pharmaceutical Solutions